NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 15, 2026 3:59:59 PM EDT
39.23USD+2.912%(+1.11)14,609,098
Pre-marketOct 15, 2026 9:29:30 AM EDT
38.93USD+2.125%(+0.81)
After-hoursOct 15, 2026 4:59:30 PM EDT
39.37USD+0.353%(+0.14)
Loading…
Loading…
173.13B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$38.12
Beta
1.03
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$42.96
SMA 200
$45.19
Avg. Vol 10D
11.78M
Avg. Vol 30D
13.28M
Avg. Vol 90D
12.50M
Relative Vol
0.85
4.41B
3.17B
71.90%
31,622,458
1.00%
1.74
54%/46%
41.74%
21.75%
0.2800%
10,000,000
192
7,421
22,844
Nov 4, 2026 (19d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 15, 2026
GLP-1s are linked to lower psychiatric hospitalizations: study · 
Seeking Alpha
Oct 14, 2026
New Peptide ETF From REX Looks Beyond GLP-1 Drugs · 
ETF Trends
Oct 13, 2026
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? · 
The Motley Fool
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.18 | 2026-10-08 | +2.75% | 0.383 |
| 1M | 42.53 | 2026-09-15 | -7.76% | -0.418 |
| 3M | 50.56 | 2026-07-15 | -22.41% | -0.348 |
| 6M | 40.81 | 2026-04-15 | -3.87% | 0.088 |
| 1Y | 56.72 | 2025-10-15 | -30.84% | 1.030 |
| 2Y | 117.81 | 2024-10-15 | -66.70% | — |
| 5Y | 51.17 | 2021-10-15 | -23.33% | 0.672 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.23, and today's volume is 11,239,108. NVO is up 2.912% today. The 30 day average volume is 13.28M. NVO market cap is $173.13B with 4.41B shares outstanding.